// App-Quantinova.ai

e17008 : Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer (mHSPC): An updated network meta-analysis and cost minimization analysis in China.

Researchers

Presenter

  • Xin Hu

Principal Investigators

  • Xingxing Yao

  • Chaoyun Li

  • Yanjun Liu

  • Tengbin Xiong

  • Shuli Qu

  • Jianye Wang

Medical Centers

  • Department of pharmacy, Beijing hospital, Beijing, China

  • Health Economics & Outcome Research, Sanofi, Shanghai, China

  • Columbia University Mailman School of Public Health, New York, NY

  • IQVIA, Shanghai, China

  • Department of pharmacy, Beijing hospital, Beijing, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved